A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy

NCT01955824 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Tuberculosis
Sarcoidosis
Interstitial Lung Disease

Interventions

DRUG: 1% lignocaine
DRUG: 2% lignocaine

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh